Evidence/1 · status: active
Evidence R6 Test
Evidence/2 · status: active
Randomized clinical trial conducted in India with 125 participants with chronic migraine. The study evaluated whether greater occipital nerve block, combined with topiramate, helped reduce monthly headache days. The treatment groups showed significant improvement, especially in achieving at least a 50% reduction in headache days by the third month.
Evidence/3 · status: active
This Evidence resource describes the placebo comparator used in a study evaluating Topamax for Migraine.
Evidence/4 · status: active
This Evidence resource describes the efficacy of placebo, from a systematic review evaluating acupuncture for the prevention of episodic migraine.
Evidence/5 · status: active
This Evidence resource describes a systematic review evaluating acupuncture for the prevention of episodic migraine.
Evidence/6 · status: active
This Evidence resource describes a systematic review evaluating acupuncture for the prevention of episodic migraine.
Evidence/7 · status: active
This Evidence resource describes a systematic review evaluating acupuncture for the prevention of episodic migraine.
Evidence/8 · status: active
Effect on fatal ICH comparing alteplase vs. placebo 3-4.5 hours after stroke
Evidence/9 · status: active
Effect on fatal ICH comparing alteplase vs. placebo 3-4.5 hours after stroke
Evidence/10 · status: active
Effect on fatal ICH comparing alteplase vs. placebo 3-4.5 hours after stroke
Evidence/11 · status: active
This Evidence resource describes a systematic review evaluating acupuncture for the prevention of episodic migraine.
Evidence/12 · status: active
This Evidence resource describes the placebo comparator used in a study evaluating acupuncture for the prevention of episodic migraine.
Evidence/13 · status: active
Test Evidence
Evidence/14 · status: active
Treatment Evidence Test
Evidence/15 · status: active
Comparator Evidence Test
Evidence/16 · status: active
This Evidence resource describes an open-label clinical study evaluating olmesartan medoxomil-based treatment for hypertension.
Evidence/17 · status: active
This Evidence resource describes an open-label clinical study evaluating olmesartan medoxomil-based treatment for hypertension.
Evidence/18 · status: active
This Evidence resource describes an open-label clinical study evaluating olmesartan medoxomil-based treatment for hypertension.
Evidence/19 · status: active
This Evidence resource describes an open-label clinical study evaluating olmesartan medoxomil-based treatment for hypertension.
Evidence/20 · status: active
This Evidence resource describes an open-label clinical study evaluating olmesartan medoxomil-based treatment for hypertension.
Evidence/21 · status: active
This Evidence resource describes an open-label clinical study evaluating olmesartan medoxomil-based treatment for hypertension.
Evidence/22 · status: active
This Evidence resource describes an open-label clinical study evaluating olmesartan medoxomil-based treatment for hypertension.
Evidence/23 · status: active
This Evidence resource describes an open-label clinical study evaluating olmesartan medoxomil-based treatment for hypertension.
Evidence/24 · status: active
This Evidence resource describes an open-label clinical study evaluating olmesartan medoxomil-based treatment for hypertension.
Evidence/25 · status: active
This Evidence resource describes an open-label clinical study evaluating olmesartan medoxomil-based treatment for hypertension.
Evidence/26 · status: active
This Evidence resource describes an open-label clinical study evaluating olmesartan medoxomil-based treatment for hypertension.
Evidence/27 · status: active
This Evidence resource describes an open-label clinical study evaluating olmesartan medoxomil-based treatment for hypertension.
Evidence/28 · status: active
This Evidence resource describes an open-label clinical study evaluating olmesartan medoxomil-based treatment for hypertension.
Evidence/29 · status: active
This Evidence resource describes an open-label clinical study evaluating olmesartan medoxomil-based treatment for hypertension.
Evidence/30 · status: active
This Evidence resource describes an open-label clinical study evaluating olmesartan medoxomil-based treatment for hypertension.
Evidence/31 · status: active
This Evidence resource describes an open-label clinical study evaluating olmesartan medoxomil-based treatment for hypertension.
Evidence/32 · status: active
This Evidence resource describes an open-label clinical study evaluating olmesartan medoxomil-based treatment for hypertension.